These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37619482)

  • 1. Melatonin as a potential treatment for septic cardiomyopathy.
    Taha AM; Mahmoud AM; Ghonaim MM; Kamran A; AlSamhori JF; AlBarakat MM; Shrestha AB; Jaiswal V; Reiter RJ
    Biomed Pharmacother; 2023 Oct; 166():115305. PubMed ID: 37619482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin: A potential protective multifaceted force for sepsis-induced cardiomyopathy.
    Casper E; El Wakeel L; Sabri N; Khorshid R; Fahmy SF
    Life Sci; 2024 Jun; 346():122611. PubMed ID: 38580195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing melatonin to combat bacterial infections and septic injury.
    Hu W; Deng C; Ma Z; Wang D; Fan C; Li T; Di S; Gong B; Reiter RJ; Yang Y
    Br J Pharmacol; 2017 May; 174(9):754-768. PubMed ID: 28213968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of melatonin treatment and combination with traditional antibiotics against septic myocardial injury.
    Di W; Jin Z; Lei W; Liu Q; Yang W; Zhang S; Lu C; Xu X; Yang Y; Zhao H
    Cell Mol Biol Lett; 2023 Apr; 28(1):35. PubMed ID: 37101253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Protective Effects of Melatonin Against LPS-Induced Septic Myocardial Injury: A Potential Role of AMPK-Mediated Autophagy.
    Di S; Wang Z; Hu W; Yan X; Ma Z; Li X; Li W; Gao J
    Front Endocrinol (Lausanne); 2020; 11():162. PubMed ID: 32373063
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence.
    Escames G; Acuña-Castroviejo D; López LC; Tan DX; Maldonado MD; Sánchez-Hidalgo M; León J; Reiter RJ
    J Pharm Pharmacol; 2006 Sep; 58(9):1153-65. PubMed ID: 16945173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: A new mechanism involving BAP31 upregulation and MAPK-ERK pathway.
    Zhang J; Wang L; Xie W; Hu S; Zhou H; Zhu P; Zhu H
    J Cell Physiol; 2020 Mar; 235(3):2847-2856. PubMed ID: 31535369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the cholinergic anti-inflammatory pathway in septic cardiomyopathy.
    Wang W; Xu H; Lin H; Molnar M; Ren H
    Int Immunopharmacol; 2021 Jan; 90():107160. PubMed ID: 33243604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of melatonin and ascorbic acid combination on sepsis-induced lung injury: An Experimental study.
    Üstündağ H; Demir Ö; Çiçek B; Huyut MT; Yüce N; Tavacı T
    Clin Exp Pharmacol Physiol; 2023 Aug; 50(8):634-646. PubMed ID: 37199082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress of mechanisms of oxidative stress in septic cardiomyopathy].
    Peng S; Zhou L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1337-1341. PubMed ID: 36567595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress of heparanase in septic cardiomyopathy: A review.
    Chen D; Wang LJ; Li HL; Feng F; Li JC; Liu L
    Medicine (Baltimore); 2024 Aug; 103(33):e38901. PubMed ID: 39151539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis-Induced Cardiomyopathy: a Comprehensive Review.
    L'Heureux M; Sternberg M; Brath L; Turlington J; Kashiouris MG
    Curr Cardiol Rep; 2020 May; 22(5):35. PubMed ID: 32377972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Septic Heart: Current Understanding of Molecular Mechanisms and Clinical Implications.
    Martin L; Derwall M; Al Zoubi S; Zechendorf E; Reuter DA; Thiemermann C; Schuerholz T
    Chest; 2019 Feb; 155(2):427-437. PubMed ID: 30171861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Mechanisms in Septic Cardiomyopathy.
    Cimolai MC; Alvarez S; Bode C; Bugger H
    Int J Mol Sci; 2015 Aug; 16(8):17763-78. PubMed ID: 26247933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin: A potential adjuvant therapy for septic myopathy.
    Liu Y; Wang D; Li T; Xu L; Li Z; Bai X; Tang M; Wang Y
    Biomed Pharmacother; 2023 Feb; 158():114209. PubMed ID: 36916434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin in septic shock: some recent concepts.
    Srinivasan V; Pandi-Perumal SR; Spence DW; Kato H; Cardinali DP
    J Crit Care; 2010 Dec; 25(4):656.e1-6. PubMed ID: 20435434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of propolis and melatonin on oxidative stress, inflammation, and clinical status in patients with primary sepsis: Study protocol and review on previous studies.
    Pahlavani N; Sedaghat A; Bagheri Moghaddam A; Mazloumi Kiapey SS; Gholizadeh Navashenaq J; Jarahi L; Reazvani R; Norouzy A; Nematy M; Safarian M; Ghayour-Mobarhan M
    Clin Nutr ESPEN; 2019 Oct; 33():125-131. PubMed ID: 31451248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of melatonin and irisin ameliorates lipopolysaccharide-induced cardiac dysfunction through suppressing the Mst1-JNK pathways.
    Ouyang H; Li Q; Zhong J; Xia F; Zheng S; Lu J; Deng Y; Hu Y
    J Cell Physiol; 2020 Oct; 235(10):6647-6659. PubMed ID: 31976559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac-targeted delivery of nuclear receptor RORα via ultrasound targeted microbubble destruction optimizes the benefits of regular dose of melatonin on sepsis-induced cardiomyopathy.
    Wang S; Chen K; Wang Y; Wang Z; Li Z; Guo J; Chen J; Liu W; Guo X; Yan G; Liang C; Yu H; Fang S; Yu B
    Biomater Res; 2023 May; 27(1):41. PubMed ID: 37147703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy.
    Pan P; Wang X; Liu D
    J Int Med Res; 2018 Jun; 46(6):2157-2169. PubMed ID: 29637807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.